Navigation Links
Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital Infections
Date:3/18/2008

NEW YORK, March 18 /PRNewswire-USNewswire/ -- A new study in the Annals of Internal Medicine adds weight to the growing evidence that screening incoming hospital patients for the bacterium MRSA (methicillin-resistant Staphylococcus aureus) is effective, and indeed essential, to reduce MRSA hospital infections. The study, published yesterday, resulted in a 70% reduction in MRSA hospital infections at the three hospitals in the Evanston Northwestern Healthcare System, located near Chicago.

This was the first "large scale, universal admission MRSA surveillance program in the United States," researchers reported, but the stunning results are consistent with at least fifty earlier studies showing that it is not possible to stop the spread of drug-resistant bacteria from patient to patient without screening. "To stop MRSA from racing through the hospital, you must know the source, that is, which patients are bringing it in," says Betsy McCaughey, Ph.D., Chairman of the Committee to Reduce Infection Deaths. "Without screening, the germs spread rapidly on equipment, lab coats, blood pressure cuffs, wheel chairs, virtually every surface. Patients who are carrying MRSA unknowingly shed it everywhere, putting the patients around them at risk."

Evanston-Northwestern researchers used a rapid test (average turnaround time from swabbing the patient to receiving test results at bedside was 18 hours). The rapid test enabled caregivers to promptly isolate patients identified as MRSA positive, use gowns, gloves and dedicated or disposable equipment when treating them, and apply mupirocin to their nasal passages and chlorhexidine to their skin to reduce the presence of the bacteria.

"This new study sets the record straight, correcting the misimpression created by an article in the Journal of the American Medical Association on March 12th suggesting that screening for MRSA was ineffective. That previous study, done in one surgical ward of a Geneva Switzerland hospital, "was seriously flawed," according to McCaughey, "rendering its findings insignificant." In that previous study, many patients were not tested until they had been in the hospital twelve hours, and test results were delayed an average of 22.5 hours after that --- a 34.5 hour delay overall. In fact, 41% of patients had already had their surgeries, before their test results were known. Consequently, the precautions, including isolation, that are supposed to be taken in response to an MRSA positive result, were not taken. The delay allowed the germ to spread to other patients.

"The evidence is overwhelming that hospitals cannot effectively prevent the spread of MRSA bacteria if they don't know which patients carry these germs," says McCaughey. "Screening saves lives. The federal Centers for Disease Control and Prevention should call on all hospitals to screen incoming patients for MRSA."


'/>"/>
SOURCE Committee to Reduce Infection Deaths
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems Assurance Pharmaceutical Care System(TM)
2. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
3. Neighborhoods play key role in how much people exercise, study says
4. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
5. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
6. Study Finds Potential Cause of Age-Related Macular Degeneration
7. New Study: Pycnogenol(R) Improves Memory in Elderly
8. Researchers study new drug and indications for heated chemotherapy treatment
9. Scripps research team wins $4M grant to study effects of chronic marijuana use
10. Meditation impacts blood pressure, study shows
11. Mayo Clinic study shows Parkinsons disease drug might work in cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
(Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
Breaking Medicine Technology: